Communiqué de presse

Eurofins achieved revenues in excess of EUR 5.4bn in 2020, after continued momentum in December across both its core business and COVID-19 related activities 25 January 2021

3 février 2021 COVID-19, Dr Gilles Martin, Eurofins

  Before the annual meeting of 300 of its Business Unit leaders on 26 January 2021, Eurofins pre-announces some of […]

Communiqué de presse

Eurofins announces its Investment Grade credit rating assigned by Moody’s

24 juillet 2020 bioanalytical testing, Dr Gilles Martin, Eurofins, Moody's, ...

24 July 2020 Eurofins Scientific (ERF FP), a global leader in bioanalytical testing, announces today that it has received its […]

Communiqué de presse

Eurofins Scientific soutient les autorités de santé dans le combat contre le COVID-19 aux Etats-Unis, en Europe et au Brésil avec des nouvelles options de tests et des capacités en augmentation rapide

19 mars 2020 Biomnis Eurofins, Dr Gilles Martin, Eurofins, Eurofins Medizinisches Labor Gelsenkirchen (Eurofins GeLaMed), ...

19 Mars 2020   Eurofins, leader mondial des laboratoires de diagnostic et de services, annonce qu’il va proposer une offre […]

Communiqué de presse

Eurofins Scientific Supports Healthcare Authorities in Europe, the U.S.A. and Brazil in their Fight against the COVID-19 Pandemic with Additional Testing Options and Fast Growing Capacity

19 mars 2020 Biomnis Eurofins, COVID-19, Diatherix Eurofins, Dr Gilles Martin, ...

  19 March 2020 Eurofins, a global leader in testing and laboratory services, announces that, in addition to the U.S.A. […]

Actualité

Freinage de l’épidémie de Covid-19

11 mars 2020 Chine, Dr Gilles Martin, Emmanuel Macron, épidémie de Covid-19, ...

  Plus de 118.619 cas dans le monde, 100 pays touchés. « “Nous avons estimé que le Covid-19 peut être […]